Le Lézard
Classified in: Health
Subjects: MAV, PSF, FVT, CFG

Notice to the media - Health Minister to announce federal measures to increase access to opioid treatment


OTTAWA, March 23, 2018 /CNW/ -  The Honourable Ginette Petitpas Taylor, Federal Minister of Health, will be announcing federal measures to increase access to opioid treatment.

Government of Canada officials will also hold a media technical briefing (teleconference only) following the Minister's remarks and media availability.

Date
March 26, 2018

Time
9:15 a.m. (EDT)? Press Conference

The Press Conference will be broadcast on Periscope Live: Periscope.tv/HealthCanada

11:30 a.m. (EDT) ? Technical Briefing

Location
Shepherds of Good Hope
3rd floor boardroom "Community Room"
256 King Edward Ave, Ottawa, ON K1N 5M9

Tech Briefing Dial in:
Toll-free dial-in number (Canada/US):
1-866-206-0153
9399557#

Notes for Media:
RSVP to [email protected] or (613) 957-2983 to receive a Technical Briefing Package

 

SOURCE Health Canada


These press releases may also interest you

at 09:50
Exegenesis Bio, a rapidly growing global genetic medicines company, is pleased to announce the presentation of clinical efficacy and safety data from its EXG001-307 Phase 1/2 clinical trial in Spinal Muscular Atrophy (SMA) Type I at the American...

at 09:47
BioAro, a pioneer in genomic research and technology, is set to officially launch PanOmiQ, a revolutionary software that will redefine the landscape of genomic analysis globally by providing real-time insights into the complexities of the human...

at 09:45
Pleio, Inc. and FountainRx announce their partnership to provide a concierge-level experience to specialty pharmacy patients. The two companies are launching a program to provide patients with human-driven support as they onboard onto their specialty...

at 09:45
JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today released a Virtual Investor "What This Means" segment featuring Moleculin Biotech , a clinical stage pharmaceutical company with a...

at 09:41
Hyundai Bioscience announced on April 25th that, after multiple consultations with global clinical research organizations (CRO), it has decided to conduct clinical trials for its 'niclosamide-based Dengue antiviral' in...

at 09:35
Inocras, a leading AI-driven whole genome testing company, proudly announces the launch of CancerVision and RareVision, its flagship whole genome diagnostics solutions in solid tumor cancer and rare disease, respectively. CancerVision and...



News published on and distributed by: